Perioperative Synbiotics Decrease Postoperative Complications in Periampullary Neoplasms: A Randomized, Double-Blind Clinical Trial

作者: Heloisa Martins Sommacal , Vivian Pierri Bersch , Santo Pascoal Vitola , Alessandro Bersch Osvaldt

DOI: 10.1080/01635581.2015.1004734

关键词: Lactobacillus rhamnosusRandomized controlled trialSurgeryComplicationMortality ratePostoperative complicationInternal medicineGastroenterologyMedicinePerioperativeSynbioticsLactobacillus casei

摘要: Periampullary neoplasms are rapidly progressive tumors with a poor prognosis and high morbidity mortality rates, which have negative influence on patient outcomes. Some probiotics prebiotics the ability to protect intestinal barrier prevent bacterial translocation, infection, postoperative complications. We evaluated use of synbiotics in prospective, double-blind study patients undergoing surgery for periampullary (PNs) assessed effect these agents nutritional status, complications, antibiotic use, length hospital stay, mortality. Patients were randomized receive prebiotics-synbiotics--group S [Lactobacillus acidophilus 10, 1 × 10(9)CFU, Lactobacillus rhamnosus HS 111, 10(9) CFU, casei Bifidobacterium bifidum, fructooligosaccharides (FOS) 100 mg]--or placebo-controls--group C, twice daily, total 14 days. Risk, clinical complication rates assessed. Twenty-three allocated each group. The incidence infection was significantly lower group (6 23 patients, 26.1%) than C (16 69.6%) (P = 0.00). Duration therapy also shorter (mean 9 days vs. 15 C; P 0.01). Noninfectious complications less common 0.03). Mean stay 12 ± 5 No deaths occurred S, whereas 6 0.02). Perioperative administration reduces PNs.

参考文章(31)
Véronique Delcenserie, D. Martel, J. Amiot, Y. Boutin, Maryse Lamoureux, Denis Roy, Immunomodulatory effects of probiotics in the intestinal tract. Current Issues in Molecular Biology. ,vol. 10, pp. 37- 54 ,(2008)
Giovanni Ramacciato, Paolo Mercantini, Niccolò Petrucciani, Giuseppe R. Nigri, Andrea Kazemi, Mirko Muroni, Massimo Del Gaudio, Albert Balesh, Matteo Cescon, Alessandro Cucchetti, Matteo Ravaioli, Risk Factors of Pancreatic Fistula after Pancreaticoduodenectomy: A Collective Review American Surgeon. ,vol. 77, pp. 257- 269 ,(2011) , 10.1177/000313481107700310
Atsushi Nashimoto, Yasumasa Takii, Otsuo Tanaka, Tatsuya Nomura, Satoru Nakagawa, Hiroshi Yabusaki, Yoshiaki Tsuchiya, Nobuaki Sato, Chizuko Kanbayashi, Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepato-gastroenterology. ,vol. 54, pp. 661- 663 ,(2007)
Stephen R. Grobmyer, Fredric M. Pieracci, Peter J. Allen, Murray F. Brennan, David P. Jaques, Defining Morbidity after Pancreaticoduodenectomy: Use of a Prospective Complication Grading System Journal of The American College of Surgeons. ,vol. 204, pp. 356- 364 ,(2007) , 10.1016/J.JAMCOLLSURG.2006.11.017
AL Hart, K Lammers, Patrizia Brigidi, Beatrice Vitali, Fernando Rizzello, Paolo Gionchetti, Massimo Campieri, MA Kamm, SC Knight, AJ Stagg, Modulation of human dendritic cell phenotype and function by probiotic bacteria Gut. ,vol. 53, pp. 1602- 1609 ,(2004) , 10.1136/GUT.2003.037325
Gerald L. Klein, Bryon W. Petschow, Audrey L. Shaw, Eric Weaver, Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Current Opinion in Supportive and Palliative Care. ,vol. 7, pp. 361- 367 ,(2013) , 10.1097/SPC.0000000000000017
Sabapathy P. Balasubramanian, Martin Wiener, Zeiad Alshameeri, Ravindranath Tiruvoipati, Diana Elbourne, Malcolm W. Reed, Standards of reporting of randomized controlled trials in general surgery: can we do better? Annals of Surgery. ,vol. 244, pp. 663- 667 ,(2006) , 10.1097/01.SLA.0000217640.11224.05
Dhiraj Yadav, Albert B. Lowenfels, The Epidemiology of Pancreatitis and Pancreatic Cancer Gastroenterology. ,vol. 144, pp. 1252- 1261 ,(2013) , 10.1053/J.GASTRO.2013.01.068
Michelle L. DeOliveira, Jordan M. Winter, Markus Schafer, Steven C. Cunningham, John L. Cameron, Charles J. Yeo, Pierre-Alain Clavien, Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Annals of Surgery. ,vol. 244, pp. 931- 939 ,(2006) , 10.1097/01.SLA.0000246856.03918.9A
Gregory Veillette, Implications and Management of Pancreatic Fistulas Following Pancreaticoduodenectomy Archives of Surgery. ,vol. 143, pp. 476- 481 ,(2008) , 10.1001/ARCHSURG.143.5.476